secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scinai Immunotherapeutics Ltd. (SCNI)
CIK:        0001611747
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001213900-23-038612
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director George H. Lowell resigns from BiondVax board, stays on Scientific Advisory Board
--------------------------------------------------------------------------------

- Resignation from Board effective May 12, 2023; served since 2008.
- Resignation not due to any disagreement with the Company's operations, policies, or practices.
- Will remain on Scientific Advisory Board and serve as liaison between Advisory Board and Board.
- Compensation for continuing role and liaison duties currently under discussion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1611747/000121390023038612/0001213900-23-038612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1611747/000121390023038612/ea178396-8k_biondvax.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-038612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer